Figure 1. TXNDC9 was upregulated in glioma tissues and cells. (A) The mRNA level of TXNDC9 in tumor and normal samples was detected by RT-PCR. n=40, *P<0.05. (B) The protein level of TXNDC9 in tumor and normal samples was detected. n=6, *P<0.05. (C) The mRNA level of TXNDC9 in different glioma cell lines (LN18, U87, U118, T98, U251) were detected by RT-PCR. NHA cell was indicated as a control. n= 6, *P<0.05. (D) The protein level of TXNDC9 in different glioma cell lines. n= 4, *P<0.05.